Click for best price
RNATargeted Small Molecule Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for RNA-Targeted Small Molecule Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-Targeted Small Molecule Drugs. This report contains market size and forecasts of RNA-Targeted Small Molecule Drugs in global, including the following market information:
Global RNA-Targeted Small Molecule Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global RNA-Targeted Small Molecule Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
mRNA Translation Regulation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA-Targeted Small Molecule Drugs include Roche, Novartis, PTC Therapeutics, Biogen, Accent Therapeutics, Anima Biotech, Arrakis Pharmaceuticals, Epics Therapeutics and Expansion Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA-Targeted Small Molecule Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-Targeted Small Molecule Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Type, 2022 (%)
mRNA Translation Regulation
RNA Splicing Modification
Direct RNA Targeting
Indirect RNA Targeting - Epitranscriptomics
Global RNA-Targeted Small Molecule Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Application, 2022 (%)
SMA
Oncology
Lung Fibrosis
Huntington's Disease
Others
Global RNA-Targeted Small Molecule Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA-Targeted Small Molecule Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNA-Targeted Small Molecule Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
PTC Therapeutics
Biogen
Accent Therapeutics
Anima Biotech
Arrakis Pharmaceuticals
Epics Therapeutics
Expansion Therapeutics
Gotham Therapeutics
H3 Biomedicine
Ribometrix
Skyhawk Therapeutics
STORM Therapeutics
Twentyeight-Seven Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-Targeted Small Molecule Drugs, market overview.
Chapter 2: Global RNA-Targeted Small Molecule Drugs market size in revenue.
Chapter 3: Detailed analysis of RNA-Targeted Small Molecule Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-Targeted Small Molecule Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
RNA-Targeted Small Molecule Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA-Targeted Small Molecule Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-Targeted Small Molecule Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-Targeted Small Molecule Drugs Overall Market Size
2.1 Global RNA-Targeted Small Molecule Drugs Market Size: 2022 VS 2029
2.2 Global RNA-Targeted Small Molecule Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-Targeted Small Molecule Drugs Players in Global Market
3.2 Top Global RNA-Targeted Small Molecule Drugs Companies Ranked by Revenue
3.3 Global RNA-Targeted Small Molecule Drugs Revenue by Companies
3.4 Top 3 and Top 5 RNA-Targeted Small Molecule Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA-Targeted Small Molecule Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Players in Global Market
3.6.1 List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-Targeted Small Molecule Drugs Market Size Markets, 2022 & 2029
4.1.2 mRNA Translation Regulation
4.1.3 RNA Splicing Modification
4.1.4 Direct RNA Targeting
4.1.5 Indirect RNA Targeting - Epitranscriptomics
4.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
4.2.1 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
4.2.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
4.2.3 By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
5.1.2 SMA
5.1.3 Oncology
5.1.4 Lung Fibrosis
5.1.5 Huntington's Disease
5.1.6 Others
5.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
5.2.1 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
5.2.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
5.2.3 By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
6.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
6.2.1 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
6.2.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
6.2.3 By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.3.2 US RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.3.3 Canada RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.3.4 Mexico RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.4.2 Germany RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.3 France RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.4 U.K. RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.5 Italy RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.6 Russia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.7 Nordic Countries RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.8 Benelux RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.5.2 China RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.3 Japan RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.4 South Korea RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.5 Southeast Asia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.6 India RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.6.2 Brazil RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.6.3 Argentina RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.7.2 Turkey RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.3 Israel RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.5 UAE RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
7 RNA-Targeted Small Molecule Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche RNA-Targeted Small Molecule Drugs Major Product Offerings
7.1.4 Roche RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis RNA-Targeted Small Molecule Drugs Major Product Offerings
7.2.4 Novartis RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 PTC Therapeutics
7.3.1 PTC Therapeutics Company Summary
7.3.2 PTC Therapeutics Business Overview
7.3.3 PTC Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.3.4 PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.3.5 PTC Therapeutics Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen RNA-Targeted Small Molecule Drugs Major Product Offerings
7.4.4 Biogen RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Accent Therapeutics
7.5.1 Accent Therapeutics Company Summary
7.5.2 Accent Therapeutics Business Overview
7.5.3 Accent Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.5.4 Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.5.5 Accent Therapeutics Key News & Latest Developments
7.6 Anima Biotech
7.6.1 Anima Biotech Company Summary
7.6.2 Anima Biotech Business Overview
7.6.3 Anima Biotech RNA-Targeted Small Molecule Drugs Major Product Offerings
7.6.4 Anima Biotech RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.6.5 Anima Biotech Key News & Latest Developments
7.7 Arrakis Pharmaceuticals
7.7.1 Arrakis Pharmaceuticals Company Summary
7.7.2 Arrakis Pharmaceuticals Business Overview
7.7.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Major Product Offerings
7.7.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.7.5 Arrakis Pharmaceuticals Key News & Latest Developments
7.8 Epics Therapeutics
7.8.1 Epics Therapeutics Company Summary
7.8.2 Epics Therapeutics Business Overview
7.8.3 Epics Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.8.4 Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.8.5 Epics Therapeutics Key News & Latest Developments
7.9 Expansion Therapeutics
7.9.1 Expansion Therapeutics Company Summary
7.9.2 Expansion Therapeutics Business Overview
7.9.3 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.9.4 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.9.5 Expansion Therapeutics Key News & Latest Developments
7.10 Gotham Therapeutics
7.10.1 Gotham Therapeutics Company Summary
7.10.2 Gotham Therapeutics Business Overview
7.10.3 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.10.4 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.10.5 Gotham Therapeutics Key News & Latest Developments
7.11 H3 Biomedicine
7.11.1 H3 Biomedicine Company Summary
7.11.2 H3 Biomedicine Business Overview
7.11.3 H3 Biomedicine RNA-Targeted Small Molecule Drugs Major Product Offerings
7.11.4 H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.11.5 H3 Biomedicine Key News & Latest Developments
7.12 Ribometrix
7.12.1 Ribometrix Company Summary
7.12.2 Ribometrix Business Overview
7.12.3 Ribometrix RNA-Targeted Small Molecule Drugs Major Product Offerings
7.12.4 Ribometrix RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.12.5 Ribometrix Key News & Latest Developments
7.13 Skyhawk Therapeutics
7.13.1 Skyhawk Therapeutics Company Summary
7.13.2 Skyhawk Therapeutics Business Overview
7.13.3 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.13.4 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.13.5 Skyhawk Therapeutics Key News & Latest Developments
7.14 STORM Therapeutics
7.14.1 STORM Therapeutics Company Summary
7.14.2 STORM Therapeutics Business Overview
7.14.3 STORM Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.14.4 STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.14.5 STORM Therapeutics Key News & Latest Developments
7.15 Twentyeight-Seven Therapeutics
7.15.1 Twentyeight-Seven Therapeutics Company Summary
7.15.2 Twentyeight-Seven Therapeutics Business Overview
7.15.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.15.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.15.5 Twentyeight-Seven Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA-Targeted Small Molecule Drugs Market Opportunities & Trends in Global Market
Table 2. RNA-Targeted Small Molecule Drugs Market Drivers in Global Market
Table 3. RNA-Targeted Small Molecule Drugs Market Restraints in Global Market
Table 4. Key Players of RNA-Targeted Small Molecule Drugs in Global Market
Table 5. Top RNA-Targeted Small Molecule Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global RNA-Targeted Small Molecule Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global RNA-Targeted Small Molecule Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies RNA-Targeted Small Molecule Drugs Product Type
Table 9. List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - RNA-Targeted Small Molecule Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global RNA-Targeted Small Molecule Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche RNA-Targeted Small Molecule Drugs Product Offerings
Table 32. Roche RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis RNA-Targeted Small Molecule Drugs Product Offerings
Table 36. Novartis RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. PTC Therapeutics Company Summary
Table 39. PTC Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 40. PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. PTC Therapeutics Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen RNA-Targeted Small Molecule Drugs Product Offerings
Table 44. Biogen RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Biogen Key News & Latest Developments
Table 46. Accent Therapeutics Company Summary
Table 47. Accent Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 48. Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Accent Therapeutics Key News & Latest Developments
Table 50. Anima Biotech Company Summary
Table 51. Anima Biotech RNA-Targeted Small Molecule Drugs Product Offerings
Table 52. Anima Biotech RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Anima Biotech Key News & Latest Developments
Table 54. Arrakis Pharmaceuticals Company Summary
Table 55. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Product Offerings
Table 56. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Arrakis Pharmaceuticals Key News & Latest Developments
Table 58. Epics Therapeutics Company Summary
Table 59. Epics Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 60. Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Epics Therapeutics Key News & Latest Developments
Table 62. Expansion Therapeutics Company Summary
Table 63. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 64. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Expansion Therapeutics Key News & Latest Developments
Table 66. Gotham Therapeutics Company Summary
Table 67. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 68. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Gotham Therapeutics Key News & Latest Developments
Table 70. H3 Biomedicine Company Summary
Table 71. H3 Biomedicine RNA-Targeted Small Molecule Drugs Product Offerings
Table 72. H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. H3 Biomedicine Key News & Latest Developments
Table 74. Ribometrix Company Summary
Table 75. Ribometrix RNA-Targeted Small Molecule Drugs Product Offerings
Table 76. Ribometrix RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Ribometrix Key News & Latest Developments
Table 78. Skyhawk Therapeutics Company Summary
Table 79. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 80. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Skyhawk Therapeutics Key News & Latest Developments
Table 82. STORM Therapeutics Company Summary
Table 83. STORM Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 84. STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. STORM Therapeutics Key News & Latest Developments
Table 86. Twentyeight-Seven Therapeutics Company Summary
Table 87. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Product Offerings
Table 88. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Twentyeight-Seven Therapeutics Key News & Latest Developments
List of Figures
Figure 1. RNA-Targeted Small Molecule Drugs Segment by Type in 2022
Figure 2. RNA-Targeted Small Molecule Drugs Segment by Application in 2022
Figure 3. Global RNA-Targeted Small Molecule Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA-Targeted Small Molecule Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA-Targeted Small Molecule Drugs Revenue in 2022
Figure 8. By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 16. US RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 20. Germany RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 28. China RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE RNA-Targeted Small Molecule Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biogen RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Anima Biotech RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Ribometrix RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
